Positive‐pressure ventilation after institution of treatment · preterm infants at risk of or with apnea; preterm infants undergoing extubation
Methylxanthine may leads to lower positive‐pressure ventilation after institution of treatment compared with placebo or control (low certainty).
1 finding from 1 review
Oxygen requirement at 36 weeks' postmenstrual age · preterm infants at risk of or with apnea; preterm infants undergoing extubation
Methylxanthine leads to lower supplemental oxygen at 36 weeks' postmenstrual age compared with placebo or control (high certainty).
1 finding from 1 review
Caesarean section · women with gestational diabetes mellitus and their babies
Fetal biometry showed no clear difference in caesarean delivery compared with maternal glycaemic values (low certainty).
1 finding from 1 review
Maternal Hypoglycaemia ‐ not reported · women with gestational diabetes mellitus and their babies
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hypertensive disorders of pregnancy · women with gestational diabetes mellitus and their babies
It is very uncertain whether fetal biometry changes hypertensive disorders of pregnancy (including pre‐eclampsia,… compared with maternal glycaemic values (very low certainty).
1 finding from 1 review
Development of T2DM in mother ‐ not reported · women with gestational diabetes mellitus and their babies
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Large‐for‐gestational age · women with gestational diabetes mellitus and their babies
It is very uncertain whether fetal biometry changes large‐for‐gestational age compared with maternal glycaemic values (very low certainty).
1 finding from 1 review
Shoulder dystocia · women with gestational diabetes mellitus and their babies
It is very uncertain whether fetal biometry changes shoulder dystocia compared with maternal glycaemic values (very low certainty).
1 finding from 1 review
Health status and well‐being – neonatal morbidity and mortality combined · women with gestational diabetes mellitus and their babies
It is very uncertain whether fetal biometry changes composite outcome neonatal morbidity or mortality compared with maternal glycaemic values (very low certainty).
1 finding from 1 review
Neonatal hypoglycaemia · women with gestational diabetes mellitus and their babies
Fetal biometry showed no clear difference in neonatal hypoglycaemia compared with maternal glycaemic values (low certainty).
1 finding from 1 review
Perinatal mortality · women with gestational diabetes mellitus and their babies
It is very uncertain whether fetal biometry changes perinatal mortality compared with maternal glycaemic values (very low certainty).
1 finding from 1 review
Disease control (time when steroid could be discontinued) · bullous pemphigoid
1 finding from 1 review
Mortality at 1 year · bullous pemphigoid
It is very uncertain whether methylprednisolone plus azathioprine changes mortality at 1 year compared with methylprednisolone plus dapsone (very low certainty).
1 finding from 1 review
Quality of life ‐ not measured · bullous pemphigoid
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events at 1 year · bullous pemphigoid
1 finding from 1 review
Any known death after randomisation (fetal, neonatal, child, child as adult) · women at risk of preterm birth
It is very uncertain whether betamethasone acetate plus phosphate changes any known death after randomisation (fetal, neonatal, child, child… compared with betamethasone phosphate – fetal/neonatal outcomes (very low certainty).
1 finding from 1 review
Respiratory distress syndrome · women at risk of preterm birth
It is very uncertain whether betamethasone acetate plus phosphate changes respiratory distress syndrome compared with betamethasone phosphate – fetal/neonatal outcomes (very low certainty).
1 finding from 1 review
Intraventricular haemorrhage · women at risk of preterm birth
It is very uncertain whether betamethasone acetate plus phosphate changes intraventricular haemorrhage compared with betamethasone phosphate – fetal/neonatal outcomes (very low certainty).
1 finding from 1 review
Necrotising enterocolitis · women at risk of preterm birth
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Chronic lung disease · women at risk of preterm birth
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found